Stockwinners Market Radar for August 23, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:04 EDT ADMA Biologics director sells $5.54M in common stock - In a regulatory filing, ADMA Biologics disclosed that its director Bryant Fong sold 1.43M shares of common stock on August 22nd in a total transaction size of $5.54M.

20:07 EDT Cathie Wood's ARK Investment sells 1.43M shares of PhenomeX today

19:44 EDT Opthea Ltd (ADR) trading halted, news pending

19:01 EDT Qantas orders 12 widebody 787 Dreamliner jets from Boeing - Boeing and the Qantas Group announced the carrier has selected the 787 Dreamliner family to modernize its widebody fleet with an order for four 787-9 and eight 787-10 airplanes. With enhanced fuel efficiency and environmental performance, the 787 Dreamliner is pivotal to Qantas' global growth strategy to reduce its carbon emissions over the next decade and beyond. "This is another multi-billion-dollar investment in the national carrier, and it's great news for our customers and our people," said Alan Joyce, Qantas Group CEO. "The 787 and the GE engines fitted to them, are thoroughly proven and extremely capable."

18:30 EDT Wendy's director Nelson Peltz sells $59M in common stock - In a regulatory filing, Wendy's disclosed that its director Nelson Peltz sold 2.9M shares of common stock on August 22nd in a total transaction size of $59M.

17:20 EDT DoorDash COO sells $1.48M in common stock - In a regulatory filing, DoorDash disclosed that its COO Prabir Adarkar sold 19.4K shares of common stock on August 21st in a total transaction size of $1.48M.

17:18 EDT Exact Sciences CFO sells $2.5M in common stock - In a regulatory filing, Exact Sciences disclosed that its CFO Jeffrey Elliott sold 30.2K shares of common stock on August 21st in a total transaction size of $2.5M.

17:15 EDT Smith-Midland Corp receives Nasdaq notice of non-compliance - Smith-Midland announced that it received a letter dated August 17, 2023, from Nasdaq, indicating that the company was not in compliance with Nasdaq listing rule 5250(c)(1), which requires the timely filing of all required periodic financial reports with the SEC. The required filing in question is the company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023. The delay in filing the Form 10-Q is related to the company's transition to a new independent registered public accounting firm as detailed in its recent filing of the Form 12b-25. The matter is not related to any of the company's internal financial reporting processes or controls. Additionally, on August 23, 2023, the company's Audit Committee of the Board of Directors approved the engagement of BDO USA, LLP as the company's new registered accounting firm. It is anticipated that BDO will commence its review of the Form 10-Q shortly, after which the company will be able to file the Form 10-Q.

17:13 EDT Lockheed Martin awarded $606.8M Navy contract modification - Lockheed Martin awarded a not-to-exceed $606.8M fixed-price incentive undefinitized modification to a previously awarded advanced acquisition contract. This modification procures long lead time materials, parts, components, and efforts in support of maintaining on-time production and delivery of 173, Lot 19, F-35 Joint Strike Fighter aircraft for Foreign Military Sales customers and non-U.S. Department of Defense participants. Work is expected to be completed in January 2028. FMS customer funds in the amount of $329.5M and non-U.S. DOD Participants Funds in the amount of $277.3M, will be obligated at time of award, none of which will expire at the end of the current fiscal year. The Naval Air Systems Command is the contracting activity.

17:02 EDT Spree Acquisition Corp. 1 and WHC terminate business combination agreement - Spree Acquisition Corp. 1 and WHC Worldwide, doing business as zTrip, a technology-based, North American-wide transportation company, have mutually agreed to terminate the previously announced Business Combination Agreement, effective immediately. Spree intends to continue to pursue the consummation of a business combination with an appropriate target.

16:50 EDT Epic Games introduces the Epic First Run program - Epic games said in an earlier blog posting: "We're introducing the Epic First Run program: an opt-in exclusivity program for third-party developers on the Epic Games Store. The new Epic First Run program gives participants the opportunity to boost their net revenue from user spending on eligible products from 88% to 100% in their first six months on the Epic Games Store. After their six-month run, participants will continue to benefit from Epic's 88%/12% revenue split. The Epic Games Store is home to a huge, rapidly growing global audience with over 230 million players and 68M monthly active users. Participating products in the Epic First Run program will be presented to those users on-store with new exclusive badging, homepage placements, and dedicated collections. In addition, products will be featured in relevant store campaigns including sales, events, and editorial as applicable. Once a product joins the program, it will benefit from continued exposure throughout its Epic First Run. The new program gives developers of any scale the opportunity to activate our global audience right at launch. While this is a major part of the release journey, that's not all of it. For this program to reach peak efficiency, developers must promote their products early and often with their target audience. Learn more about publishing best practices by reading our marketing tips found in our Developer Resources Documentation. The Epic First Run program is open to developers and publishers on the Epic Games Store with eligible new releases launching on or after October 16." The Fly notes that Epic Games is a privately owned company. CEO Tim Sweeney owned more than half of its shares, while the Chinese technology and entertainment holding company Tencent (TCEHY) held a 40% stake in the game maker. Other companies in the space include: Electronic Arts (EA), Activision Blizzard (ATVI), Take-Two (TTWO) Nintendo (NTDOY), Sony (SONY), Microsoft (MSFT), and Nintendo (NTDOY). Reference Link

16:29 EDT Magnite Director Spillane sells $201K in company shares - Magnite Director Robert Spillane disclosed the sale of 25,000 shares of company stock at $8.05 per share on August 22, for a total transaction amount of $201,250.

16:25 EDT Nvidia approves additional $25B in share repurchases - "During the second quarter of fiscal 2024, NVIDIA returned $3.38 billion to shareholders in the form of 7.5 million shares repurchased for $3.28B, and cash dividends. As of the end of the second quarter, the company had $3.95B remaining under its share repurchase authorization. On August 21, 2023, the Board of Directors approved an additional $25.00B in share repurchases, without expiration. NVIDIA plans to continue share repurchases this fiscal year. NVIDIA will pay its next quarterly cash dividend of 4c per share on September 28, 2023, to all shareholders of record on September 7," the company stated.

16:23 EDT Nvidia up 6% after better than expected Q2 results, Q3 guidance - Nvidia shares are up $29.88, or 6%, to $501.04 in after-hours trading.

16:19 EDT TechnipFMC awarded significant installation contract by TotalEnergies - TechnipFMC (FTI) has been awarded a significant contract to install flexible pipe and associated subsea structures for the Girassol Life Extension project by TotalEnergies EP Angola (TTE) and its Block 17 Partners. The Company was previously awarded the engineering, procurement, and supply of subsea flowlines and connectors for GIR LIFEX last year. Jonathan Landes, President, Subsea at TechnipFMC, commented: "The seamless integration of engineering, manufacturing, and installation provides our clients with the flexibility and agility they need to meet their project goals. We have good knowledge of this field, having built the subsea tree systems for the original Girassol development. It gives us immense pride that our long-term clients continue to show trust and confidence in our solutions through subsequent awards." For TechnipFMC, a "significant" contract is between $75M and $250M.

16:17 EDT CVS Health launches Cordavis subsidiary - CVS Health announced that it has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products for the U.S. pharmaceutical market. The Cordavis products will be FDA approved, high quality, and easy for patients to use and will help ensure consistent long-term supply of affordable biosimilars. As its first product, Cordavis has contracted with Sandoz to commercialize and bring to market Hyrimoz, a biosimilar for Humira, in the first quarter of 2024 under a Cordavis private label. The list price of the Cordavis Hyrimoz will be more than 80% lower than the current list price of Humira.

16:10 EDT Regeneron VP Stahl sells $9.8M in company shares - Regeneron VP Neil Stahl disclosed the sale of 11,665 shares of company stock at $840.98 per share on August 22, for a total transaction amount of $9,810,083.

16:08 EDT Snowflake sees Q3 product revenue up 28%-29% from last year at $670M-$675M - Sees Q3 operating margin of 4%.

16:07 EDT Snowflake reports Q2 net revenue retention rate of 142% - Reports Q2 had 402 customers with trailing 12-month product revenue greater than $1 million

15:33 EDT Salem Media enters agreement to sell Greenville-Spartanburg radio stations - Salem Media Group announced that it entered into an agreement to transfer the ownership of its Greenville-Spartanburg stations, WGTK-FM, WRTH-FM, and WLTE-FM to Educational Media Foundation.

15:08 EDT Esmark says will not make bid for U.S. Steel - Esmark, Inc. confirmed that it will not participate in the purchase process for U.S. Steel Corporation. "Esmark had previously stated its intention to bid for, and negotiate a purchase with, U.S. Steel. Esmark respects the position of the United Steelworkers (USW) which is supporting Cleveland Cliff's offer for U.S. Steel. Esmark maintains a solid working and personal relationship with the USW organization and its leadership," the company stated in a press release. "The USW was our partner in the successful acquisition of Wheeling Pittsburgh Steel, and we remain close with them. The U.S. Steel board must go through their process that they previously announced. We wish them the best during this process, and we will evaluate any opportunities in connection with that process, subject to support from the USW," added Jim Bouchard, Esmark Chairman and CEO.

14:36 EDT Mullen CEO 'disappointed' by stock performance, says recently purchased shares - Mullen Automotive shared an open letter to Mullen shareholders addressing declining stock values, in which CEO and Chairman David Michery stated in part: "The company has received numerous requests to respond to the ongoing decline of our stock. Many of these communications have been addressed to me personally with less than kind, and sometimes threatening statements. As CEO of this company, I take all shareholders' concerns seriously. One of my primary responsibilities is to execute the company's business plan, and as evidenced by multiple prior communications to the public, the company continues to make significant strides in that regard. I will summarize some of those at the end of this statement. I am very disappointed by the performance of our stock. As I have previously publicly stated, I do not believe the trading price of our stock even closely resembles the company's actual value. It is evident that, regardless of meeting significant corporate milestones (i.e., vehicle production completion within projected timelines), stock traders continue to place downward pressure on the stock, causing the price to fall. I previously announced that the company engaged Share Intel and other parties to investigate what I suspect to be unlawful trading practices in our stock. We are assembling all the data received to date and should have something to announce in the coming days. I am extremely frustrated that the hard work of Mullen's dedicated team and the significant momentum and successes achieved to date are overshadowed by the unrealistic value attributed to our stock. The company and I have demonstrated our commitment to the success of our initiatives by purchasing its stock through the previously announced Share Buy Back program. I have also personally recently purchased stock, demonstrating my unwavering confidence in our company. I remain committed to executing the company's business plan and using all measures at our disposal to eliminate any unlawful trading practices in our stock."

13:57 EDT NextGen Healthcare up 8% after Reuters says company exploring possible sale

13:12 EDT Citi revamps U.S. Retail Bank with simplified banking and reduced service fees - "Citi's U.S. Retail Bank introduces simplified banking, a more straightforward way of banking. By retiring account packages and introducing Relationship Tiers, Citi is streamlining its benefits and services and enhancing the customer experience. New customers can benefit from these changes immediately and Citi will begin converting existing customers to simplified banking in 2024," said the bank in a statement. "Customers are at the heart of everything we do, and we are excited to offer even more enhanced offerings with convenient benefits and services that grow with customers as they move through life's stages," said Craig Vallorano, Head of Retail Banking at Citi. "These latest changes are designed to create a more seamless experience for our customers and make it easier for them to get personalized advice and access their finances." Citi is expanding on its commitment to make banking more accessible and inclusive for people across the income spectrum. Customers not in a Relationship Tier can avoid Monthly Service Fees in their Citi Checking account by making Enhanced Direct Deposits of $250 or more each month; in their Citi Savings account by having $500+ or more in Average Monthly Balance or owning both a Citi Checking and Savings account; and during the month they open an account and for three calendar months after account opening. Since summer 2022, Citi has defined Enhanced Direct Deposits to include deposits via Zelle and other peer-to-peer payments when made via the Automated Clearing House using providers such as Venmo or PayPal. This policy helps to remove a barrier that workers may face who primarily receive income through peer-to-peer payments. Beginning in 2022, Citi has eliminated a number of its retail consumer banking fees, including overdraft fees, returned item," noted the bank in a statement.

13:12 EDT Citi revamps U.S. Retail Bank with simplified banking and reduced service fees - "Citi's U.S. Retail Bank introduces simplified banking, a more straightforward way of banking. By retiring account packages and introducing Relationship Tiers, Citi is streamlining its benefits and services and enhancing the customer experience. New customers can benefit from these changes immediately and Citi will begin converting existing customers to simplified banking in 2024," said the bank in a statement. "Customers are at the heart of everything we do, and we are excited to offer even more enhanced offerings with convenient benefits and services that grow with customers as they move through life's stages," said Craig Vallorano, Head of Retail Banking at Citi. "These latest changes are designed to create a more seamless experience for our customers and make it easier for them to get personalized advice and access their finances." Citi is expanding on its commitment to make banking more accessible and inclusive for people across the income spectrum. Customers not in a Relationship Tier can avoid Monthly Service Fees in their Citi Checking account by making Enhanced Direct Deposits of $250 or more each month; in their Citi Savings account by having $500+ or more in Average Monthly Balance or owning both a Citi Checking and Savings account; and during the month they open an account and for three calendar months after account opening. Since summer 2022, Citi has defined Enhanced Direct Deposits to include deposits via Zelle and other peer-to-peer payments when made via the Automated Clearing House using providers such as Venmo or PayPal. This policy helps to remove a barrier that workers may face who primarily receive income through peer-to-peer payments. Beginning in 2022, Citi has eliminated a number of its retail consumer banking fees, including overdraft fees, returned item," noted the bank in a statement.

12:55 EDT Questor Technology announces departure of CEO Audrey Mascarenhas - Questor Technology announces the departure of President and CEO, Audrey Mascarenhas, effective today. Mascarenhas has also resigned from the board of directors. The board is working on a transition plan that it expects to have completed in the near term. During this transition period, board member Derek O'Malley-Keyes will act as interim President and CEO.

12:02 EDT Sony to launch PlayStation Portal remote device later this year - In a blog post, Sony unveiled the PlayStation Portal remote player, a dedicated PlayStation 5 remote play device. "PlayStation Portal remote player brings the PS5 experience to the palm of your hand. It includes the key features of the DualSense wireless controller, including adaptive triggers and haptic feedback," the company said. "The vibrant 8-inch LCD screen is capable of 1080p resolution at 60fps, providing a high definition visual experience that's expected from the high quality games created by world-class developers. PlayStation Portal is the perfect device for gamers in households where they might need to share their living room TV or simply want to play PS5 games in another room of the house. PlayStation Portal will connect remotely to your PS5 over Wi-Fi, so you'll be able to swiftly jump from playing on your PS5 to your PlayStation Portal. PlayStation Portal can play supported games that are installed on your PS5 console and use the Dualsense controller. It also includes a 3.5mm audio jack for wired audio. PS VR2 games, which require the headset, and games that are streamed through PlayStation Plus Premium's cloud streaming, are not supported." The device will launch later this year for $199.99. Reference Link

12:00 EDT Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -8.1% - Direxion Daily Junior Gold Miners Index Bear 3x Shares is down -8.1%, or -61c to $6.92.

12:00 EDT Williams-Sonoma rises 12.6% - Williams-Sonoma is up 12.6%, or $15.83 to $140.98.

12:00 EDT Arcus Biosciences rises 28.0% - Arcus Biosciences is up 28.0%, or $5.26 to $24.07.

11:06 EDT Stellantis completes agreement with AGI to support electrification effort - Stellantis and its U.S. dealership network are "driving toward their electrified future" with the selection of AGI to be "a turnkey infrastructure solutions provider to help dealers in their electrification effort and all aspects required to build out electric vehicle supply equipment for charging," the company announced. "Working with its 2,600-plus dealers, the company is focused on the transition to electric-vehicle sales and service. The addition of AGI's electrical engineering, project management, fabrication and maintenance capabilities will provide an additional significant resource for Stellantis dealers to help accelerate their electric-vehicle readiness. The move adds AGI to the Stellantis U.S. roster of EV infrastructure and training partners, including Future Energy and Vehya," Stellantis said.

11:01 EDT Avangrid announces Camino Solar, its first photovoltaic project in California - Avangrid announced that it will build the Camino Solar project, its first solar project in California, a state in which the company currently operates more than 500 MW through six wind energy facilities. To be constructed by Cupertino Electric, Inc. in Kern County, the project is adjacent to Avangrid's 189 MW Manzana Wind farm and will employ more than 100 people during construction. The project is expected to be commercially operational in 2025 and will generate roughly $15.5M in local taxes during its lifetime.

10:38 EDT Greenidge Generation reports victory in water permit case - Greenidge Generation responded to the dismissal of a lawsuit filed by Earthjustice on behalf of Seneca Lake Guardian, Committee to Preserve the Finger Lakes and the Sierra Club regarding Greenidge's water discharge permit. "The case marks the fourth time opponents have sued Greenidge in state or federal court since 2016, and opponents have lost all six rulings in the cases and related appeals," according to the company. Greenidge Generation President Dale Irwin added: "You can write the script in advance: file a superficial lawsuit, get some media attention, and then lose in court because you have no grounds. They don't file lawsuits, they issue press releases dressed up as lawsuits and simply waste the courts' and taxpayers' time and money... Efforts like this latest failed lawsuit are why nobody in the Finger Lakes listens to these gadflies anymore; they have zero credibility." Reference Link

10:33 EDT Tiziana Life Sciences appoints William Clementi as chief development officer - Tiziana Life Sciences announced that it has appointed William A. Clementi, Pharm.D., FCP as Chief Development Officer. Dr. Clementi will formally take up the CDO role effective September 1, 2023. In this role, Dr. Clementi will be responsible for overseeing the company's development strategies and advancing its portfolio of therapeutic candidates. Clementi said, "I am excited to join Tiziana Life Sciences and contribute to the advancement of its innovative therapeutic candidates. I am excited to apply my regulatory and drug development experience and skills to Tiziana and contribute to the leadership team. The company's commitment to addressing unmet medical needs and its dedication to scientific excellence are truly inspiring. I look forward to working closely with the talented team at Tiziana to drive the development of novel treatments that have the potential to make a meaningful impact on patients' lives."

10:24 EDT Digital Brands Group Inc trading halted, volatility trading pause

10:20 EDT Foot Locker notes weaker start to back-to-school season - The company said on its earnings conference call that the full weight of the macro environment on lower income consumers became more evident through Q2, including a weaker start to the back-to-school season.

10:01 EDT Humana announces agreement with Interwell Health - Humana and kidney care management company Interwell Health, have announced a new value-based care agreement in 13 states for most Humana Medicare Advantage HMO and PPO members living with chronic kidney disease, as well as members across the country living with end-stage kidney disease. Humana said that with this new agreement, these members have access throughout their healthcare journey to Interwell's comprehensive care and specialized resources, including 1,700 network nephrologists, renal care coordinators, and in-home virtual support from dietitians, nurses, social workers, pharmacists, and care coordinators. The 13 states where this value-based care program for CKD is now available are Arizona, Arkansas, Colorado, Kansas, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, and West Virginia.

10:00 EDT CVR Energy falls -5.0% - CVR Energy is down -5.0%, or -$1.75 to $32.93.

10:00 EDT Vtex rises 11.8% - Vtex is up 11.8%, or 68c to $6.43.

10:00 EDT Arcus Biosciences rises 32.0% - Arcus Biosciences is up 32.0%, or $6.02 to $24.83.

09:49 EDT Exicure names Paul Kang as CEO, Jiyoung Hwang as CFO - Exicure announced that, effective as of August 21, 2023, Paul Kang, a Class III director, was appointed as CEO of the company and Jiyoung Hwang, a Class I director, was appointed as CFO. Kang and Hwang succeed Jung-Sang "Michael" Kim, who stepped down as CEO and CFO last Friday. Additionally, effective as of August 21, 2023, the Board also approved the appointment of Hyuk Joon "Raymond" Ko as a Class III director, Dongho Lee as a Class I director, and Hojoon Lee as a Class II director of the Board. The new directors will be replacing the vacancies created by the resignations of Kim and Changil Ahn last Friday. "We are glad that management, the Board and our controlling stockholders are now fully aligned in our strategic vision for the future of the Company, and we will be focusing on real steps to maximize value for all stockholders of the Company in the coming months," said Kang of the renewed management and Board.

09:47 EDT LiveWire falls -5.9% - LiveWire is down -5.9%, or -68c to $10.93.

09:47 EDT Vtex rises 13.7% - Vtex is up 13.7%, or 79c to $6.54.

09:47 EDT Arcus Biosciences rises 25.5% - Arcus Biosciences is up 25.5%, or $4.80 to $23.61.

09:44 EDT VFS Stock trading halted, volatility trading pause

09:39 EDT Thermo Fisher up 4% after Reuters report of Wegovy filling contract

09:33 EDT iTeos jumps after Roche inadvertently publishes positive TIGIT data - Shares of iTeos Therapeutics (ITOS) have jumped $4.82, or 41%, to $16.57 in early trading after Roche (RHHBY) on Tuesday night inadvertently disclosed positive results from a closely watched lung cancer drug study. The second interim look at Roche's SKYSCRAPER-01 trial leaked last night and the combo of TIGIT tiragolumab and PD-L1 Tecentriq vs Tecentriq alone in NSCLC appeared to be trending towards a survival benefit and the data looked "good," which is likely to renew TIGIT interest, BofA has told investors.

09:11 EDT Great Lakes awarded dredge, disposal contract for Port Arthur LNG Project - Great Lakes Dredge & Dock Corporation announced the award for the Port Arthur LNG Phase 1 project Marine Dredging and Disposal contract. Great Lakes has been contracted by Bechtel Energy, a leading global engineering, construction, and procurement company that's managing the Port Arthur LNG Phase 1 project in partnership with Sempra Infrastructure. The Port Arthur LNG project is a natural gas liquefaction and export terminal in Southeast Texas with direct access to the Gulf of Mexico. The facilities will include two natural gas liquefaction trains with a nameplate capacity of approximately 13 million tonnes per annum. The project will also include construction of new natural gas pipelines to deliver natural gas to the terminal. Lasse Petterson, Great Lakes' President and Chief Executive Officer commented, "We are pleased to play a critical role in this important project that will help meet growing global demand for natural gas, in addition to supporting economic growth across Texas and the Gulf Coast region. With this contract, Great Lakes' backlog and recent pending awardable work now exceed $1 billion. Our proven performance and safety culture allows us to support the growth of LNG export in the U.S., which is a necessity in balancing energy affordability and overall sustainability."

09:07 EDT Senmiao reports July completed orders 690,000 vs. 740,000 in June - Senmiao Technology announced the operating metrics for its proprietary online ride-hailing platform for the month of July. In July Senmiao and its affiliates recorded 690,000 total completed orders, compared to 740,000 total orders completed in June. The decrease was primarily a result of a compliance check performed by Gaode, Senmiao's online ride-hailing platform partner under the original model, which caused a decrease in completed orders in Senmiao's major market of Guangzhou during the period. The Company expects the number of rides from Gaode to normalize in late August. Numbers reported include the number of completed orders from several ride-hailing platforms in Chengdu, utilizing Senmiao's network of cars and drivers for a set monthly fee.

09:06 EDT African Gold Acquisition Corp trading halted, news dissemination

09:05 EDT Olin announces agreement to acquire the assets of White Flyer Targets - Olin Corporation announced an agreement to acquire the assets of White Flyer Targets, North America's preeminent leader in recreational trap, skeet, and sporting clay targets, and combine it with the Winchester Ammunition business. The acquisition includes White Flyer's five state of the art manufacturing facilities in Coal Township, Pennsylvania; Dalton, Georgia; Webb City, Missouri; Knox, Indiana; and, San Bernardino, California and includes White Flyer's recently announced ECO FLYER target product line. The transaction is contingent on Olin's completion of confirmatory due diligence, definitive agreements, and final approval of both companies' Boards of Directors. The transaction is not expected to require any premerger filings and is expected to be completed in the Q4. Olin would fund the transaction with cash on hand and anticipates that the transaction would be immediately accretive to Olin's shareholders.

09:04 EDT GRI Bio enters into asset purchase agreement with Aardvark for sale of ADAIR - GRI Bio announced that the Company has entered into an asset purchase agreement pursuant to which Aardvark Therapeutics will acquire certain assets and intellectual property of the Company that pertain to ADAIR. Aardvark intends to utilize the ADAIR formation technology for the development of certain follow-on pipeline programs. Under the terms of the agreement, Aardvark will assume responsibility for and endeavor to develop and commercialize the purchased assets. Exclusive license rights to develop and commercialize ADAIR in Europe and the UK were previously licensed to Medice Arzneimittel Putter GmbH, a leader in the European ADHD market. GRI Bio will receive a modest up-front payment and the potential to earn milestone payments for achievements in development and commercialization from Aardvark up to approximately $80 million. "This agreement represents a great opportunity for GRI Bio as it allows us to optimize our non-strategic asset that we acquired through our merger with Vallon, while allowing us to maintain our focus on advancing our pipeline of novel assets in development for inflammatory and fibrotic diseases. We believe in the potential of ADAIR and are pleased to have it continue on in its development at Aardvark," commented Marc Hertz, PhD, Chief Executive Officer of GRI Bio.

09:02 EDT Liquid Media receives Nasdaq delisting notice - Liquid Media Group announced that on August 21, 2023, the Company was notified by The Nasdaq Stock Market LLC that, based upon the Company's continued non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), and the filing requirement set forth in Nasdaq Listing Rule 5250(c)(1), the Company's securities will be suspended from trading on Nasdaq effective with the open of business on Wednesday, August 23, 2023. Following the lapse of any applicable Nasdaq review and appeal periods, Nasdaq will file a Form 25 to formally effect the delisting of the Company's securities from the exchange. The Company is seeking to have its common shares quoted on the OTC Markets system. Further information on this transition will follow as it becomes available.

09:01 EDT Cemtrex announces share repurchase program for up to 2.3M shares - Cemtrex announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up 2,300,000 shares of its outstanding Series 1 Preferred Stock from time-to-time commencing September 1, 2023 and ending on August 31, 2026, subject to market conditions. "Cemtrex's Board of Directors and management team believe that the market currently undervalues our business," commented Saagar Govil, CEO of Cemtrex. "The share repurchase program provides us with flexibility to repurchase the preferred stock over time if market conditions persist."

09:01 EDT WISeKey launches VAULTIC292 cryptographic module - WISeKey International Holding announced that its Semiconductors & PKI subsidiary, SEALSQ is introducing the VAULTIC292 - a cutting-edge secure element tailored for IoT devices and sensors.

08:51 EDT Thoma Bravo completes acquisition of ForgeRock - Thoma Bravo and ForgeRock announced the completion of Thoma Bravo's acquisition of ForgeRock in an all-cash transaction valued at approximately $2.3B. The acquisition agreement was previously announced on October 11, 2022, and approved by ForgeRock stockholders at ForgeRock's Special Meeting of Stockholders held on January 12. Upon completion of the acquisition, ForgeRock stockholders are entitled to receive $23.25 in cash for each share of ForgeRock class A common stock and class B common stock they owned. ForgeRock's class A common stock will no longer trade and will be delisted from the New York Stock Exchange. Thoma Bravo also announced that it has combined ForgeRock into its portfolio company Ping Identity. "The combined company is positioned to better serve customers across the dynamic and fast-growing Identity and Access Management market by providing enhanced products and services, broader geographic support, and increased innovation. The combined company will seek to accelerate the delivery of identity security experiences for the customers, employees, and partners of companies worldwide," the firm stated.

08:44 EDT Citi revamps U.S. Retail Bank with simplified banking and reduced service fees - "Citi's U.S. Retail Bank introduces simplified banking, a more straightforward way of banking. By retiring account packages and introducing Relationship Tiers, Citi is streamlining its benefits and services and enhancing the customer experience. New customers can benefit from these changes immediately and Citi will begin converting existing customers to simplified banking in 2024," said the bank in a statement. "Customers are at the heart of everything we do, and we are excited to offer even more enhanced offerings with convenient benefits and services that grow with customers as they move through life's stages," said Craig Vallorano, Head of Retail Banking at Citi. "These latest changes are designed to create a more seamless experience for our customers and make it easier for them to get personalized advice and access their finances." Citi is expanding on its commitment to make banking more accessible and inclusive for people across the income spectrum. Customers not in a Relationship Tier can avoid Monthly Service Fees in their Citi Checking account by making Enhanced Direct Deposits of $250 or more each month; in their Citi Savings account by having $500+ or more in Average Monthly Balance or owning both a Citi Checking and Savings account; and during the month they open an account and for three calendar months after account opening. Since summer 2022, Citi has defined Enhanced Direct Deposits to include deposits via Zelle and other peer-to-peer payments when made via the Automated Clearing House using providers such as Venmo or PayPal. This policy helps to remove a barrier that workers may face who primarily receive income through peer-to-peer payments. Beginning in 2022, Citi has eliminated a number of its retail consumer banking fees, including overdraft fees, returned item," noted the bank in a statement.

08:39 EDT BioSig Technologies introduces new subscription model for PURE EP platform - BioSig Technologies announced a subscription model for its PURE EP Platform. Cleveland Clinic-recently ranked as number one in the Nation for cardiology, heart & vascular surgery by U.S. News & World Report-is first to sign an agreement to acquire the PURE EP Platform under the subscription model. BioSig has made the move to a subscription model so that electrophysiologists and cardiology departments can access the latest features with the ability to customize the rich suite of PURE EP software capabilities to suit their needs. The proprietary combination of hardware and software empowers electrophysiologists with real-time, ultra-pure, cardiac signal data, with the potential to improve arrhythmia care and procedures. "Cleveland Clinic approached us with the idea to conduct research evaluating the utility and impact of our novel signal applications. A portion of this foundational research was presented at HRS 2023, and we were excited to collaborate with their world-class team of electrophysiologists," commented Zach Koch, Principal Product Advisor of BioSig. "With a rich history of medical innovation and breakthroughs, Cleveland Clinic has piloted many cutting-edge cardiovascular technologies that are recognized as the standard of care today. We are proud to witness PURE EP in use at their clinic and excited to see their commitment to innovation continue as the first subscription-based customer, unlocking the full spectrum of clinical, operational, and economic benefits of the PURE EP Platform in a fully customizable package."

08:38 EDT Immix Biopharma receives orphan drug designation for NXC-201 - Immix Biopharma announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation designation for NXC-201 for the treatment of a life-threatening form of blood cancer, multiple myeloma. NXC-201, a next generation CAR-T cell therapy, is currently being evaluated in a Phase 1b/2a clinical trial NEXICART-1.

08:37 EDT Ageagle Aerial Systems says Kelluu to equip airships with RedEdge-P cameras - AgEagle Aerial Systems announced that Kelluu Ltd., a privately-owned Finnish company engaged in the design, manufacture and operation of autonomous airships for aerial environmental and critical infrastructure monitoring and surveillance, has chosen to equip its growing fleet of unmanned airships with AgEagle's high performance RedEdge-P multispectral cameras for collection of high quality images and sensor data. Based in Joensuu, Finland, Kelluu has pioneered low-emission, hydrogen-powered airships that can remain airborne for more than 12 hours per mission. With its airships, Kelluu offers commercial enterprises and government agencies with data-as-a-service, specializing in monitoring and providing real-time, actionable intelligence on power lines, roads and railways, as well as surveilling and monitoring potential environmental issues associated with forest lands and water bodies across Finland - and soon across Central Europe.

08:36 EDT BTC Digital announces share consolidation - BTC Digital announced that the Company plans to effect a share consolidation of 20 ordinary shares with par value of 0.3c per share each in the Company's issued and unissued share capital into 1 ordinary share with par value of 6c. As a result of the Share Consolidation, each 20 pre-consolidation ordinary shares outstanding will automatically combine and convert into one issued and outstanding ordinary share without any action on the part of the shareholders. The Share Consolidation will be effective on August 23. Beginning with the opening of trading on August 24 the Company's ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "METX" but under a new CUSIP number of G6055H 155. No fractional shares will be issued in connection with the Share Consolidation. All fractional shares will be rounded up to the whole number of shares. Immediately following the Share Consolidation, the authorized share capital of the Company will be $1.50M divided into 25,000,000 ordinary shares of a par value of 6c each.

08:35 EDT Mallinckrodt confirms plans to file for chapter 11 bankruptcy - Mallinckrodt announced it has entered into a Restructuring Support Agreement with a substantial majority of each of the company's first and second lien debtholders and the Opioid Master Disbursement Trust II on the terms of a comprehensive financial restructuring plan that will reduce the company's total funded debt by approximately $1.9B, increase free cash flow generation, extend maturity runway and better position the business for long-term success. The RSA also provides for, among other consideration, a final payment of $250M to the Trust, in addition to the $450M previously paid, to support the Trust's mission to address the U.S. opioid crisis and fund addiction treatment. To implement the financial restructuring plan contemplated by the RSA, the company intends to initiate voluntary prepackaged Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware in the coming days. "Due to the overwhelming support of its key stakeholders, the company expects to complete the contemplated prepackaged Chapter 11 process in the fourth quarter of 2023. Mallinckrodt is operating normally, supporting patients with high-quality therapies, serving customers and working with its business partners, and it fully expects to continue doing so throughout the contemplated court-supervised process. Additionally, the company's Specialty Generics business will continue to abide by previously agreed upon compliance and monitoring measures. The company also fully intends to continue supporting patient groups and patient advocacy programs, including through its Patient Advocacy Advisory Board and patient assistance programs," the company stated. "After several months of constructive discussions, we are pleased to have reached this agreement with our key stakeholders, which will enable Mallinckrodt to better align our balance sheet with our current business plan," said Siggi Olafsson, President and CEO of Mallinckrodt. "While we have made important progress over the past year, the steps we are taking now will strengthen our ability to navigate the challenges that have affected our business. As we move forward, we remain focused on advancing our business priorities and operational initiatives, including seeking growth opportunities across our portfolio and executing on our recent and planned product launches. Delivering therapies that improve outcomes for patients with severe and critical conditions remains at the center of all that we do." Olafsson continued, "We appreciate the constructive engagement with our creditors in determining the best path forward for the business and our patients, customers, partners and employees. We also recognize the important role of the Trust in helping to address the U.S. opioid crisis and have remained committed to ensuring that we achieved a meaningful resolution for the Trust through this process. We also thank our patients, customers and partners for their continued support, and we are grateful to our employees for their ongoing hard work and commitment to the patients we serve. We expect to complete this process on an expedited basis, well-positioned to continue delivering high-quality therapies."

08:34 EDT Adial Pharmaceuticals regains compliance with Nasdaq listing requirements - Adial Pharmaceuticals announced that it received notice from Nasdaq on August 21, 2023 that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). Nasdaq determined that for the last 10 consecutive business days, from August 7 through August 18, 2023, the closing bid price of the Company's common stock has been at $1.00 per share or greater. Additionally, on August 22, 2023, the Company received notice from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. The Company has now successfully resolved both outstanding Nasdaq compliance issues and Nasdaq has advised that the matters are now closed.

08:33 EDT Bridgeline Digital announces Digible expanded its investment in WooRank - Bridgeline Digital announced that Digible, a top multifamily apartments marketing agency, expanded its investment in WooRank, Bridgeline's SEO tool, to power their revenue and growth. The Colorado-based agency will leverage WooRank SEO to accelerate its client's online presence with WooRank's SEO insights for search engine optimization. Ari Kahn, CEO of Bridgeline Digital, said, "We're excited to further support Digible in their mission. We aim to help them achieve greater online growth and increased revenue for their clients."

08:25 EDT Mallinckrodt confirms chapter 11 bankruptcy - Mallinckrodt announced it has entered into a Restructuring Support Agreement with a substantial majority of each of the company's first and second lien debtholders and the Opioid Master Disbursement Trust II on the terms of a comprehensive financial restructuring plan that will reduce the Company's total funded debt by approximately $1.9B, increase free cash flow generation, extend maturity runway and better position the business for long-term success. The RSA also provides for, among other consideration, a final payment of $250M to the Trust, in addition to the $450M previously paid, to support the Trust's mission to address the U.S. opioid crisis and fund addiction treatment. To implement the financial restructuring plan contemplated by the RSA, the company intends to initiate voluntary prepackaged Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware in the coming days. Due to the overwhelming support of its key stakeholders, the company expects to complete the contemplated prepackaged Chapter 11 process in the fourth quarter of 2023. Mallinckrodt is operating normally, supporting patients with high-quality therapies, serving customers and working with its business partners, and it fully expects to continue doing so throughout the contemplated court-supervised process. Additionally, the company's Specialty Generics business will continue to abide by previously agreed upon compliance and monitoring measures. The company also fully intends to continue supporting patient groups and patient advocacy programs, including through its Patient Advocacy Advisory Board and patient assistance programs. "After several months of constructive discussions, we are pleased to have reached this agreement with our key stakeholders, which will enable Mallinckrodt to better align our balance sheet with our current business plan," said Siggi Olafsson, President and CEO of Mallinckrodt. "While we have made important progress over the past year, the steps we are taking now will strengthen our ability to navigate the challenges that have affected our business. As we move forward, we remain focused on advancing our business priorities and operational initiatives, including seeking growth opportunities across our portfolio and executing on our recent and planned product launches. Delivering therapies that improve outcomes for patients with severe and critical conditions remains at the center of all that we do." Olafsson continued, "We appreciate the constructive engagement with our creditors in determining the best path forward for the business and our patients, customers, partners and employees. We also recognize the important role of the Trust in helping to address the U.S. opioid crisis and have remained committed to ensuring that we achieved a meaningful resolution for the Trust through this process. We also thank our patients, customers and partners for their continued support, and we are grateful to our employees for their ongoing hard work and commitment to the patients we serve. We expect to complete this process on an expedited basis, well-positioned to continue delivering high-quality therapies."

08:20 EDT CACI announces $125M contract to provide C5ISR support for NAWCAD - CACI International announced that it was awarded a five-year single-award, indefinite delivery indefinite quantity mission technology contract, called Crisis Response and Interoperable C5 Electronic Systems, CRIC-ES, valued at up to $125M for the U.S. Navy's Naval Air Warfare Center Aircraft Division, NAWCAD. CACI has supported the NAWCAD for more than 30 years. "CACI has a long history with the Navy, and we are proud of the NAWCAD's continued confidence in us as the most proficient provider to meet the C5ISR needs of our warfighters," said John Mengucci, CACI President and Chief Executive Officer. "Our dedicated team will continue to deliver mission-specific, advanced solutions at a rapid pace to ensure the success of the Navy's crisis responders." On this contract, which was awarded in the fourth quarter of fiscal year 2023, CACI will continue to provide vital full life cycle support for Command, Control, Computers, Communications, Cyber, Intelligence, Surveillance, and Reconnaissance C5ISR systems, including engineering and design, rapid prototyping, fabrication, and integration. These tailored C5ISR solutions operate on multiple platforms supporting on-the-ground end users such as Department of Defense Combatant Commands and disaster recovery/first responders

08:18 EDT Fiverr CEO 'stands in agreement' with ruling on copyright of AI-generated work - Micha Kaufman, CEO of Fiverr, announced his support of DC District Court Judge Beryl A. Howell's ruling that AI-generated work devoid of human intervention cannot be granted copyright protection. "We support this ruling. This is what we've been saying all along," Kaufman said. "We at Fiverr know that while AI can be a powerful tool in the creative process, it's the human element that imbues work with originality." Fiverr's platform is built upon the principle of human collaboration, where freelancers from around the world bring their expertise to cater to the diverse needs of businesses. Every project commissioned on Fiverr involves direct interaction and input from human creators, ensuring that each piece of work carries a distinct and personalized touch. "If you are hiring a freelancer on Fiverr, you are getting authentic copyrightable services because you're always dealing with humans," Kaufman points out. "Fiverr's commitment to the sanctity of human creativity aligns with Judge Howell's ruling, which notes that human authorship is a bedrock requirement of copyright."

08:17 EDT MediGene expands IP license for costimulatory switch proteins - Medigene announces the expansion of the IP license for its PD1-41BB and CD40L-CD28 costimulatory switch proteins, enabling their application to additional cell types and for use in Chimeric Antigen Receptor T cell therapies. Medigene's PD1-41BB and CD40L-CD28 costimulatory switch protein technologies were developed by its partner Helmholtz Munich and are exclusively licensed to Medigene. With the expansion of the IP license to include various cell types beyond T cell receptor engineered T cells, Medigene significantly enhances the potential use of both costimulatory switch proteins, which are currently combined with the Company's specific, sensitive and safe T cell receptors, across various cell types beyond T cells. This provides an opportunity to leverage the advantages of other immune cells and enhance the tumor cell killing activity, proliferation and persistence of its TCR-based therapies. In addition, this IP license expansion enables Medigene to potentially enhance the efficacy of CAR-T therapies in patients who relapse and do not respond adequately to earlier lines of therapy due to the upregulation of PD-L1 in certain cancers.

08:15 EDT Windtree Therapeutics announces issuance of composition of matter patent - Windtree Therapeutics reported that the United States Patent and Trademark Office, USPTO, has issued US Patent No. 11,730,746 covering the Company's dual mechanism SERCA2a Activators. The new composition of matter patent, titled: "17BETA-HETEROCYCLYL-DIGITALIS LIKE COMPOUNDS FOR THE TREATMENT OF HEART FAILURE," provides patent protection through late 2039. The newly issued patent follows the Company's announcement in April 2023 that the European Patent Office granted Patent No. 3599243, which also provides patent coverage for the dual mechanism SERCA2a Activator class of drug candidates. "We are making steady progress with our IP portfolio strategy for the dual mechanism SERCA2a Activator family of drug candidates," said Craig Fraser, Chief Executive Officer of Windtree Therapeutics. "We plan to position these new compounds as a 'fast follow-on' to istaroxime while offering the potential of oral bioavailability for use as a treatment for chronic heart failure. Much may be accomplished for heart failure patient treatment with this innovation."

08:14 EDT Baudax Bio announces distribution of Series C Preferred Stock - Baudax Bio announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock, par value $0.01 per share, for each outstanding share of the Company's common stock held of record as of 5:00 p.m. Eastern Time on September 5, 2023. The shares of Series C Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Time on September 7, 2023. The outstanding shares of Series C Preferred Stock will vote together with the outstanding shares of the Company's common stock, as a single class, exclusively with respect to a proposal to approve a reverse stock split, as well as any proposal to adjourn any meeting of shareholders called for the purpose of voting on the reverse stock split, and will not be entitled to vote on any other matter, except to the extent required under the Pennsylvania Business Corporation Law. Subject to certain limitations, each outstanding share of Series C Preferred Stock will have 1,000,000 votes per share. All shares of Series C Preferred Stock that are not present in person or by proxy at the meeting of shareholders held to vote on the reverse stock split as of immediately prior to the opening of the polls at such meeting will automatically be redeemed by the Company and shall have no voting power. Any outstanding shares of Series C Preferred Stock that have not been so redeemed will be redeemed if such redemption is ordered by the Company's Board of Directors or automatically upon the approval by the Company's shareholders of an amendment to the Company's articles of incorporation effecting the reverse stock split at such meeting. The Series C Preferred Stock will be uncertificated, and no shares of Series C Preferred Stock will be transferable by any holder thereof except in connection with a transfer by such holder of any shares of the Company's common stock held by such holder. In that case, a number of one one-thousandths of a share of Series C Preferred Stock equal to the number of shares of the Company's common stock to be transferred by such holder would be transferred to the transferee of such shares of common stock.

08:12 EDT Jaguar Global Growth I announces appointees for Captivision board - Under the terms of the business combination agreement, Captivision's board will consist of seven directors. The appointees are highly qualified individuals who bring extensive expertise and complementary skills. Set out below are Captivision's board member appointees with brief background information on each: Gary R. Garrabrant is the Chairman and CEO of Jaguar Global, as well as the CEO and co-founder of both Jaguar Growth Partners Group and JGP. Ho Joon Lee is an award-winning executive and entrepreneur with a background in technology, media and communications, and finance. Dr. Lee is the co-founder of GLAAM. Betty Liu is an accomplished entrepreneur, journalist, producer, and corporate executive, with over 25 years of professional experience in the United States and internationally. Michael Berman has years of experience leading financial functions for public companies and is an expert in real estate. Currently, Mr. Berman is the CEO of MB Capital Associates. Craig Hatkoff is a veteran leader in commercial real estate and global digital infrastructure, having served on the board of directors of several public companies in the real estate industry. Jessica Thomas has extensive experience in the media industry. She is currently a Partner at William Morris Endeavor Hafeez Giwa has nearly 20 years of professional experience in the global real estate investment industry. Mr. Giwa is the Founder and Managing Partner of H Capital International.

08:11 EDT Bullfrog AI technology named finalist in R&D 100 awards - BullFrog AI Holdings announced that its machine learning/artificial intelligence technology, exclusively licensed from the Johns Hopkins University Applied Physics Lab, has been selected as a finalist in the IT/Electrical category for the R&D 100 Awards. The designation recognizes APL's Prometheus/Euclid/Seagull algorithm suite as a leading-edge library integrating probabilistic modeling, graph analysis, and time series analysis to solve complex data challenges. "We are honored that the proprietary machine learning technology for which we hold exclusive global licensing rights from APL has been named a finalist for the R&D 100 Awards," stated Vin Singh, CEO of BullFrog AI. "We believe that any powerful solution for the pharmaceutical industry needs to lead with great technology and this designation further validates the best-in-class capability of our bfLEAP(TM) AI platform to glean insights from incomplete data sets, in a transparent and explainable manner, that reveal patterns and relationships to better predict how patients and drug compounds will respond in clinical trials."

08:09 EDT ProSomnus announces updated trial data on FLOSAT - ProSomnus announced updated clinical trial data, presented at the ProSleep 2023 Users Conference earlier this month. The updated data indicate that the First Line Obstructive Sleep Apnea Treatment study, FLOSAT, is on track to achieve all endpoints. Key findings to date include: Precision oral appliance therapy is effective, and non-inferior to CPAP, as a first-line treatment for moderate to severe OSA; Precision OAT was effective among 90% of moderate and 85% of severe OSA patients; Precision oral appliance therapy was preferred by patients, with 98% continuing therapy at three months versus 22% discontinuing CPAP therapy over the same period of time; In an intention to treat analysis factoring efficacy and adherence, precision OAT demonstrated twice the mean disease alleviation as CPAP. "The updated data and analysis from FLOSAT is validation that precision oral appliance therapy with ProSomnus devices is an effective front-line treatment for moderate to severe OSA," said Len Liptak, Co-Founder and Chief Executive Officer of ProSomnus. "This is an important finding. Each year millions of people worldwide are diagnosed with moderate to severe OSA. An estimated 40% of them refuse CPAP. Over two and a half million people have been impacted by the recent CPAP recall and seek alternatives. The results of this study indicate that precision OAT with ProSomnus devices is an effective, and preferred, option for these patients."

08:08 EDT Transcode announces first subject dosed in Phase 0 trial of TTX-MC138 - TransCode Therapeutics announced the dosing of the first subject in its First-in-Human Phase 0 clinical trial. The Phase 0 trial is an open-label, single-center, microdose study intended to demonstrate delivery of the radio-labeled version of TransCode's lead therapeutic candidate, TTX-MC138, to radiographically-confirmed metastases in subjects with advanced solid tumors. "We are pleased to have commenced our First-in-Human (FIH) clinical trial," said TransCode's Chief Executive Officer and co-founder, Michael Dudley. "The capability to deliver nucleic-acid based therapeutics to cancer represents a major turning point in the field of RNA because it opens up the possibility of developing an entire new class of drugs against most previously undruggable genetic targets. Overcoming this challenge could constitute an unprecedented step in unlocking therapeutic access to a range of cancers and beyond. Demonstrating successful delivery to cancer using TransCode's proprietary TTX delivery platform could also enable progress towards more personalized cancer therapy guided by genetic profiling.

08:06 EDT VCI Global announces visionary collaboration with Microsoft Azure OpenAI - VCI Global (VCIG) announced that through its wholly-owned subsidiary, V Galactech Sdn Bhd, it has teamed up with the Microsoft (MSFT) Azure OpenAI platform. This partnership acknowledges the screaming demand and dedication to transform the dynamic tech landscape as businesses move towards borderless and seamless frontiers at neck breaking speeds to efficiently engage its customers, amongst others. "VCI Global is thrilled to be further involved in AI-related innovations and more so, with Microsoft Azure OpenAI. We are ecstatic for this partnership to be up and running as we look forward to transforming how companies engage customers in the dynamic tech landscape where the level of transformation can only be limited by our imagination and creativity. This partnership will accelerate our growth in the AI industry, further strengthening our capabilities to transform the businesses of our clients," said Dato' Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global.

08:05 EDT NV5 Global awarded $25M in resident inspection services by NYCDDC - NV5 Global has been awarded a $16M extension to an existing resident engineering inspection services contract by the New York City Department of Design and Construction. NV5 has also been issued a $9M task order to provide resident engineering inspection services for the reconstruction of Trinity Place in Lower Manhattan. In addition to reconstruction of the roadway, the project's scope will include extensive upgrades to the City's sewer system and electric and gas infrastructure.

08:04 EDT Cerence selected by Boson Motors to enhance in-vehicle experience - Cerence announced that Boson Motors, a Bay Area-based electric truck company, has selected Cerence to enhance the in-vehicle experience in its wide range of electric trucks. This marks an important design win for Cerence as it expands into new areas of transportation, including trucking. "As Cerence expands to new areas of transportation, we're proud to partner with OEMs like Boson Motors, who is leading an important transformation in trucking through advanced electrification and autonomy," said Stefan Ortmanns, CEO, Cerence. "By integrating Cerence TTS into the in-vehicle experience, Boson will bring an enhanced level of productivity and emotional intelligence to its electric trucks, advancing toward an immersive in-vehicle experience."

08:03 EDT Trio Petroleum second test interval at HV-1 discovery well to be Brown Zone - Trio Petroleum announced that the second test interval at the HV-1 discovery well of the South Salinas Project will be the Brown Zone, of the Miocene Age Monterey Formation. The Brown Zone and the overlying Yellow Zone are the primary reservoir objectives of the HV-1 well and both are attributed oil and gas reserves in the Company's Reserve Report as filed with the SEC. The first test interval, the Mid-Monterey Clay, is a deeper stratigraphic interval that is not attributed oil and/or gas reserves in the Company's Reserve Report but which, nevertheless, and importantly, appears to potentially be capable of commercial oil and gas production at the HV-1 well. Thus, the Brown-Zone test will be the first test in the HV-1 well of the Company's reserves as delineated in the Company's Reserve Report as filed with the SEC. The current plan is to perforate and acidize approximately 350 feet of the Brown Zone in an interval from approximately 5,465 to 5,850 feet measured depth and to then test the well via swabbing operations. Operations may commence during the week of August 28, with initial production results estimated one or two weeks thereafter.

08:02 EDT Super League Gaming partners with Claire's for Roblox Limiteds platform - Super League and Claire's are teaming up and kicking off their partnership as early brand leaders of the Roblox Limiteds platform, an exciting digital merchandise feature allowing creators and brands to release limited UGC designs and quantities of unique wearable creations across the Roblox platform.

07:53 EDT Sneaker makers slide after Foot Locker cuts outlook - Shares of sneaker and athletic apparel makers Nike (NKE) and Under Armour (UAA) are down 3.5% to $97.95 and 1.5% to $7.09, respectively, in pre-market trading after Foot Locker (FL) cut its FY23 adjusted EPS view and revenue outlook. Mary Dillon, Foot Locker president and CEO, said, "Our second quarter was broadly in line with our expectations, despite the still-tough consumer backdrop. However, we did see a softening in trends in July and are adjusting our 2023 outlook to allow us to best compete for price-sensitive consumers, while still leaning into the strategic investments that drive our Lace Up plan."

07:40 EDT FTI Consulting expands partnership with Reveal - FTI Consulting announced that the firm's Technology segment has further expanded its existing partnership with Reveal, the global provider of a leading artificial intelligence-powered e-discovery, review and investigations platform. In addition to existing global data hosting and early case assessment offerings with Reveal, FTI Technology now leverages an expanded suite of Reveal's sentiment analysis and custom multi-modal classification workflows. The addition of these features to FTI Technology's disputes and investigations offerings will enhance e-discovery processes with advanced artificial intelligence capabilities and enable new workflows for validating document productions.

07:38 EDT Brainsway announces expanded availability of Deep TMS technology in Taiwan - BrainsWay announced the expanded availability of its Deep Transcranial Magnetic Stimulation technology in Taiwan. BrainsWay's most recent delivery of systems is expected to bring its installed base in this important Asia Pacific country to 16 Deep TMS systems, including another 5 systems planned for installation before the end of the current quarter.

07:34 EDT Orbital receives letter from Nasdaq regarding late filing of quarterly report - Orbital Infrastructure Group announced that it received a letter from The Nasdaq Stock Market on August 18 notifying the Company that the Company's failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30 in violation of Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250 serves as an additional basis for delisting the Company's securities from Nasdaq, and the Nasdaq Hearings Panel will consider this matter in rendering a determination regarding the Company's continued listing on Nasdaq. As previously disclosed, on December 28, 2022, the Company was notified by Nasdaq that the market value of its listed securities had been below the $35M minimum required for continued listing as set forth in Nasdaq Listing Rule 5550 for the previous 30 consecutive trading days. The Company was provided 180 calendar days, or until June 26 to regain compliance with Nasdaq Listing Rule 5550. To date, the Company has not regained compliance with Nasdaq Listing Rule 5550.

07:31 EDT Verrica issues statement in support of FDA's letters on treatment of MC - Verrica Pharmaceutical issued a statement in support of the U.S. Food and Drug Administration's, FDA, recent action against retailers and manufacturers of unapproved products for the treatment of molluscum contagiosum, MC. "On the heels of the June 1, 2023 FDA warning to consumers not to use unapproved products for the treatment of molluscum contagiosum, we are pleased the FDA is taking additional measures against these unapproved products," said Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals. "It is clear that the FDA views molluscum as a serious health problem that requires medical intervention with therapies that have been rigorously tested and properly reviewed. Verrica has conducted two Phase 3 trials to demonstrate the clinical safety and efficacy of YCANTH, so that the millions of people, primarily children, who suffer from this viral infection can finally receive a safe, effective, and FDA-approved treatment for their condition."

07:28 EDT Alterity Therapeutics granted new composition of matter patent in Europe - Alterity Therapeutics announced the European Patent Office has granted Alterity a new composition of matter patent. The patent secures broad protection over a new class of iron chaperone drug candidates for treating major neurodegenerative diseases. It is well established that excess iron in the brain is implicated in the pathology of many important neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The patent, entitled, "Compounds for and Methods of Treating Diseases", Patent No. 3938364, is effective 23 August 2023 when published in the European Patent Bulletin. The composition of matter patent covers more than 150 novel pharmaceutical compositions that are designed to redistribute the excess iron implicated in neurodegenerative diseases. The patent will confer on Alterity 20 years of exclusivity over the compounds claimed in the patent, thus providing a strong basis for drug development and commercialization.

07:25 EDT Peloton down 27% at $5.12 after Q4 earnings miss, below-consensus guide

07:21 EDT Draganfly awarded Canadian Provincial wildfire services contract - Draganfly announced it will be providing drone pilot crews and drone technology to a Canadian Provincial Government to assist with firefighting mitigation, preparedness, response, and recovery efforts. Draganfly's advanced drone technology and highly trained personnel will aid emergency services in their mission to protect lives, property, infrastructure, and ecosystems. Draganfly will help conduct night-time missions, identify fire line breaches, and detect hidden hot spots using thermal imaging technology. Draganfly's services will enhance the firefighting operations, which protect critical infrastructure, towns, valuable natural resources, and help mitigate air quality hazards from the devastating impact of these wildfires.

07:19 EDT Peloton reports Q4 subscribers down 29K from Q3 - CEO Barry McCarthy writes: "We ended Q4 with 4% Y/Y Connected Fitness (CF) subscription growth, but subscribers declined by 29 thousand on a Q/Q basis due to the seasonal slowdown in hardware sales and higher than anticipated CF subscription churn. The slowdown exceeded our expectations through May and through the first three weeks of June as consumer spending shifted toward travel and experiences. Then eight weeks ago the trend reversed itself, and we began to see a reacceleration in hardware sales. Growth also was slowed by the seat post recall we announced on May 11th in so far as first party and third party sales of our original Peloton Bike were supply constrained by seat post availability. To date we've received approximately 750 thousand requests for replacement seat posts, which was more than we expected. We've fulfilled over 340 thousand of these requests and expect to fulfill the balance by the end of September, which is slower than Members wanted but 3 months sooner than we had originally communicated to Members."

07:13 EDT Foot Locker pauses dividend - Mary Dillon, President and CEO, said, "We remain committed to our Lace Up plan as introduced at our March 2023 Investor Day, and we are encouraged by the progress we are making against our strategic priorities heading towards the holiday season. To ensure that we have the flexibility to continue to fund our strategic investments appropriately, we are pausing our quarterly cash dividend beyond our Board's recently-approved October payout. We intend to update the market on our go-forward capital allocation plans and the timing around our longer-term financial targets when we report fourth quarter results."

07:04 EDT Cyngn and Arauco to deploy first DriveMod Forklifts in Bennettsville facility - Cyngn and Arauco, a global sustainable forestry products, pulp, and engineered wood supplier to the furniture and construction industries, announced the plan to deploy Cyngn's first DriveMod Forklifts to Arauco's Bennettsville, South Carolina facility. Arauco is a well-known and established wood products supplier with over $7B in revenue in 2022.

07:01 EDT Ideanomics announces 1-for-125 reverse stock split - Ideanomics announced that its Board of Directors has approved a reverse stock split of its common stock, par value 0.1c per share at a ratio of 1-for-125. The Reverse Stock Split is expected to become effective on August 25 and the shares are expected to begin trading on the split-adjusted basis on the Nasdaq under the Company's existing trading symbol "IDEX" at market open on August 25, 2023, upon Nasdaq's approval. The new CUSIP number following the Reverse Stock Split will be 45166V205. The Reverse Stock Split is primarily being enacted to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550.

06:56 EDT Asensus Surgical announces agreement with First Towakai Hospital - Asensus Surgical announced that First Towakai Hospital has entered into an agreement to lease and utilize a Senhance Surgical System in their urology and gynecology centers and gastroenterology department. First Towakai Hospital is a community-based medical institution situated in Takatsuki City, Osaka Prefecture.

06:44 EDT Advance Auto Parts cuts FY23 CapEx view to $200M-$250M from $250M-$300M - Cuts FY23 free cash flow view to $150M-$250M from $200M-$300M. Backs FY23 new store openings of 40-60.

06:40 EDT Advance Auto Parts interim CFO sees 'additional headwinds' in 2H23 - Tony Iskander, interim CFO, said, "We are updating our full-year guidance, which considers a modest step up in net and comparable store sales growth driven by strengthening of our professional business. However, we are reducing our outlook for operating income margin rate, diluted earnings per share and free cash flow. This reflects additional headwinds anticipated in the back half of the year driven by our ongoing commitment to maintain competitive price targets, impacts from a shift in channel mix and investments in our team to help retain top talent."

06:37 EDT Aliant Communications to hold inaugural investor and analyst day - Allient will hold its inaugural investor and analyst day beginning at 11:00 am ET today in New York City. During the presentation, Dick Warzala, Chairman, President and CEO, Mike Leach, CFO, and other members of the Company's leadership team will provide an in-depth update on its strategic progress, future targets, and the strategy to achieve those goals. Warzala, commented, "For the past 20 years, we have successfully executed our strategy and expanded our capabilities to be a leading global provider of motion solutions. More recently, we have been building our controls and power technologies capabilities, both organically and through acquisitions. The evolution of these additional pillars of our business enhances our overall value proposition and expands our addressable markets. Our advancements required a refinement of our strategy to leverage the value opportunity that exists at the nexus of our three technology pillars - Motion, Controls and Power. Overall, the breadth and depth of our technology offerings, expanded market opportunities and an increased focus on offering solutions for targeted vertical markets creates a path to achieve our growth goals. We believe in time we can generate over $1B in annual revenue, expand gross margin and deliver operating margin in the mid-teens leading to adjusted EBITDA margin in the high-teens."

06:35 EDT Advance Auto Parts says Shane O'Kelly to succeed Tom Greco as CEO - Advance Auto Parts (AAP) announced that its board of directors has appointed Shane O'Kelly as president and CEO, effective September 11. O'Kelly will succeed Tom Greco, who has served as president and CEO since April 2016. Greco announced his planned retirement in February 2023 and will stay on as an advisor to ensure a seamless transition. O'Kelly has also been appointed to the Advance Auto Parts board of directors, effective September 11, 2023. Gene Lee, interim executive chair of the board of directors, will continue in his interim role through the end of the year. Most recently, O'Kelly served as CEO of HD Supply, a wholly owned subsidiary of The Home Depot (HD).

06:33 EDT Parsons acquires Sealing Technologies for $200M - Parsons Corporation announced that it has acquired Maryland-based cyber and technology company Sealing Technologies in a transaction valued at up to $200M. SealingTech expands Parsons' customer base across the Department of Defense and Intelligence Community. The transaction is consistent with Parsons' strategy of completing accretive acquisitions of companies with revenue growth and adjusted EBITDA margins each exceeding 10%, while adding critical intellectual property that strengthens the company's existing portfolio. SealingTech's nearly 150 employees, 70% of whom hold security clearances, will be aligned to Parsons' Defense & Intelligence business unit, with its capabilities being leveraged across both Parsons' Federal Solutions and Critical Infrastructure segments, customers, and projects. Parsons is paying $175M of cash at closing for SealingTech, with an additional $25M earn out payable in Q1 of FY25 if certain revenue targets are met during 2024. After factoring in a $21M transaction-related tax benefit, the base purchase price implies a 10x multiple on SealingTech's forecasted 2023e adjusted EBITDA before considering any revenue or cost synergies. Parsons estimates SealingTech will generate $110M of revenue in 2024 and that the transaction will be accretive to Parsons' fiscal year 2024 revenue growth rate, adjusted EBITDA margin, and adjusted earnings per share. Barclays acted as financial advisor and Jenner & Block acted as legal advisor to Parsons. SealingTech was advised by Chesapeake Corporate Advisors and Nemphos Braue.

06:21 EDT Johnson & Johnson reports final results from Kenvue exchange offer - Johnson & Johnson (JNJ) announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue (KVUE) common stock owned by Johnson & Johnson. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023. Pursuant to the exchange offer, Johnson & Johnson has accepted 190,955,436 shares of Johnson & Johnson common stock in exchange for 1,533,830,450 shares of Kenvue common stock. Because the exchange offer was oversubscribed, Johnson & Johnson accepted only a portion of the shares of its common stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Shareholders who owned fewer than 100 shares of Johnson & Johnson common stock, or an "odd-lot," who validly tendered all of their shares, were not subject to proration, in accordance with the terms of the exchange offer. All shares validly tendered by eligible "odd-lot" shareholders were accepted. The final proration factor of 23.231832% was applied to all other validly tendered shares of Johnson & Johnson common stock to determine the number of such shares that were accepted. Following completion of the exchange offer, Johnson & Johnson retains approximately 9.5% of the outstanding shares of Kenvue common stock.

06:07 EDT Dycom sees Q3 revenues in line with Q3 of FY22 - The Company expects organic contract revenues for the Q3 to be in line with contract revenues for the same quarter of last year. In addition, the Company expects approximately $30M of acquired contract revenues for the Q3. Non-GAAP Adjusted EBITDA as a percentage of contract revenues for the Q3 is expected to increase 50 to 100 basis points as compared to the Q3 of last year.

05:22 EDT Embraer granted Type Certificate by CAAC - Embraer E195-E2, the largest member of the E-Jet family, has been granted its Type Certificate by the Civil Aviation Administration of China, or CAAC. This follows the certification of the E190-E2 received from CAAC in November last year, during the Zhuhai Air Show.

05:14 EDT Parsons awarded five-year contract by KAFD DMC - Parsons announced that the company was awarded a five-year contract by the King Abdullah Financial District Development and Management Company, or KAFD DMC, for project and construction management services in Saudi Arabia's prime business and lifestyle destination, the King Abdullah Financial District, or KAFD. The contract supports the expansion of KAFD in new, undeveloped land. Located in the heart of Riyadh, the capital of Saudi Arabia, KAFD features 1.6M square meters of office space, facilities, and luxury residences designed to transform how urban communities live, work, and play. It is the first vertical city solution in Saudi Arabia, comprising a five-asset class mixed use living district, a key driver of Riyadh's economic ambitions and the world's largest LEED-certified mixed-use financial district. KAFD is owned and managed by the King Abdullah Financial District Development and Management Company.